SyImmune (Syntrion GmbH)
Welcome to the PulseAid listing for the SyImmune drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Syntrion GmbH |
NON-PROPRIETARY NAME: | PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM |
SUBSTANCE NAME: | PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2014-01-10 |
END MARKETING DATE: | 2019-08-31 |
SyImmune HUMAN OTC DRUG Details:
Item Description | SyImmune from Syntrion GmbH |
LABELER NAME: | Syntrion GmbH |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2014-01-10 |
END MARKETING DATE: | 2019-08-31 |
PRODUCT ID: | 10424-107_152bd7e9-28cc-44b1-96de-2af85d873b83 |
PRODUCT NDC: | 10424-107 |
APPLICATION NUMBER: | |
Other PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM Pharmaceutical Manufacturers / Labelers: